Sunshine Biopharma (SBFM) Revenue & Revenue Breakdown
Sunshine Biopharma Revenue Highlights
Latest Revenue (Y)
$39.85M
Latest Revenue (Q)
$9.30M
Sunshine Biopharma Revenue by Period
Sunshine Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $39.85M | 816.94% |
| 2022-12-31 | $4.35M | 1802.41% |
| 2021-12-31 | $228.43K | 219.88% |
| 2020-12-31 | $71.41K | 238.10% |
| 2019-12-31 | $21.12K | -95.28% |
| 2018-12-31 | $447.20K | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | -100.00% |
| 2015-12-31 | $1.71K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-07-31 | - | 100.00% |
| 2007-07-31 | - | - |
Sunshine Biopharma generated $39.85M in revenue during NA 2023, up 816.94% compared to the previous quarter, and up 8910.20% compared to the same period a year ago.
Sunshine Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $9.30M | 23.37% |
| 2024-03-31 | $7.54M | -1.81% |
| 2023-12-31 | $7.68M | 28.91% |
| 2023-09-30 | $5.96M | 7.14% |
| 2023-06-30 | $5.56M | 13.62% |
| 2023-03-31 | $4.89M | 24.22% |
| 2022-12-31 | $3.94M | 2866.57% |
| 2022-09-30 | $132.81K | -11.64% |
| 2022-06-30 | $150.31K | 22.55% |
| 2022-03-31 | $122.64K | 44.09% |
| 2021-12-31 | $85.12K | 68.97% |
| 2021-09-30 | $50.38K | -4.72% |
| 2021-06-30 | $52.87K | 31.99% |
| 2021-03-31 | $40.06K | 43.00% |
| 2020-12-31 | $28.01K | 63.34% |
| 2020-09-30 | $17.15K | 13.24% |
| 2020-06-30 | $15.14K | 36.42% |
| 2020-03-31 | $11.10K | 5.17% |
| 2019-12-31 | $10.56K | 44.09% |
| 2019-09-30 | $7.33K | 141.54% |
| 2019-06-30 | $3.03K | -97.47% |
| 2019-03-31 | $119.73K | 7.05% |
| 2018-12-31 | $111.84K | -18.33% |
| 2018-09-30 | $136.94K | 27.68% |
| 2018-06-30 | $107.25K | 17.64% |
| 2018-03-31 | $91.17K | 171.33% |
| 2017-12-31 | $33.60K | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $68.14K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | -100.00% |
| 2015-06-30 | $1.71K | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-10-31 | - | 100.00% |
| 2009-07-31 | - | 100.00% |
| 2009-04-30 | - | 100.00% |
| 2009-01-31 | - | 100.00% |
| 2008-10-31 | - | 100.00% |
| 2008-07-31 | - | 100.00% |
| 2008-04-30 | - | - |
Sunshine Biopharma generated $9.30M in revenue during Q2 2024, up 23.37% compared to the previous quarter, and up 190.09% compared to the same period a year ago.
Sunshine Biopharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| LFCR | Lifecore Biomedical | $128.26M | $35.70M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| DERM | Journey Medical | $79.18M | $14.86M |
| SBFM | Sunshine Biopharma | $39.85M | $9.30M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| SNOA | Sonoma Pharmaceuticals | $12.73M | $3.44M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| SHPH | Shuttle Pharmaceuticals | - | - |
SBFM Revenue FAQ
What is Sunshine Biopharma’s yearly revenue?
Sunshine Biopharma's yearly revenue for 2023 was $39.85M, representing an increase of 816.94% compared to 2022. The company's yearly revenue for 2022 was $4.35M, representing an increase of 1802.41% compared to 2021. SBFM's yearly revenue for 2021 was $228.43K, representing an increase of 219.88% compared to 2020.
What is Sunshine Biopharma’s quarterly revenue?
Sunshine Biopharma's quarterly revenue for Q2 2024 was $9.3M, a 23.37% increase from the previous quarter (Q1 2024), and a 67.30% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.54M, a -1.81% decrease from the previous quarter (Q4 2023), and a 54.09% increase year-over-year (Q1 2023). SBFM's quarterly revenue for Q4 2023 was $7.68M, a 28.91% increase from the previous quarter (Q3 2023), and a 94.94% increase year-over-year (Q4 2022).
What is Sunshine Biopharma’s revenue growth rate?
Sunshine Biopharma's revenue growth rate for the last 3 years (2021-2023) was 17343.90%, and for the last 5 years (2019-2023) was 188557.75%.